Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. proudly announces that its self-developed Active Pharmaceutical Ingredient (API), Apalutamid...

To All Colleagues and Partners Time surges forward, and our journey of striving never pauses. As we bid farewell to the o...

As the year 2026 approaches, we at Shandong Chenghui Pharmaceutical extend our warmest wishes to our global partners and clients. May the New Year...

On December 19, 2025, our company reached a pivotal milestone in international pharmaceutical development, as the European Pharmacopoeia Suitability ...

On November 10, 2025, our company successfully obtained approval for the European CEP registration of our active pharmaceutical ingredient (API), Lido...

From October 28th to 30th, 2025, Shandong Chenhui Pharmaceutical Group made a remarkable appearance at the CPHI Worldwide Europe exhibition in Frankf...

Achinery Exhibition (Pharmtech & Ingredients) will be held at the Crocus Expo IEC in Moscow. Shandong Chenghui Pharmaceutical Group will s...

From November 12th to 14th, 2025, the 93rd China International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Trade Fair (API China) ...